U.S. FDA approves Gilead’s Bixlenvo for HIV adults
U.S. FDA approved Gilead’s Bixlenvo, a once-daily single-tablet option for virologically suppressed adults with HIV, including those on complex regimens.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.